We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Avalo Therapeutics Inc is a clinical-stage precision medicine company that discovers, develops, and commercializes targeted therapeutics for patients with significant unmet clinical needs in immunology, immuno-oncology, and rare genetic diseases. Its pipeline consists of product candidates advancing... Avalo Therapeutics Inc is a clinical-stage precision medicine company that discovers, develops, and commercializes targeted therapeutics for patients with significant unmet clinical needs in immunology, immuno-oncology, and rare genetic diseases. Its pipeline consists of product candidates advancing in development with ongoing clinical programs: AVTX-002, AVTX-007, and AVTX-006. Show more
Appointments include industry veterans Aaron Kantoff, Jonathan Goldman, and Samantha Truex as Independent DirectorsBoard of Director appointments in conjunction with Avaloβs recent acquisition of...
Acquired AVTX-009, Phase-2 ready anti-IL-1Ξ² mAb, in March 2024Increased cash position with private placement financing in March 2024 providing up to $185 million, including initial upfront...
Avalo acquires Phase 2-ready anti-IL-1Ξ² mAb, AVTX-009, through acquisition of AlmataBio, Inc. Topline results from planned Phase 2 trial in hidradenitis suppurativa expected in 2026Executed...
WAYNE, Pa. and ROCKVILLE, Md., Dec. 27, 2023 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc. (Nasdaq: AVTX) today announced a 1-for-240 reverse stock split of the Companyβs common stock, par value...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -4.47 | -27.5925925926 | 16.2 | 17.42 | 11.25 | 72069 | 13.25152093 | CS |
4 | -3.03 | -20.5284552846 | 14.76 | 18.79 | 11.25 | 91294 | 14.39157516 | CS |
12 | 6.67 | 131.818181818 | 5.06 | 34.46 | 4.18 | 723733 | 19.35170621 | CS |
26 | -13.95 | -54.3224299065 | 25.68 | 34.46 | 3.9501 | 8599499 | 15.75096807 | CS |
52 | -621.87 | -98.1486742424 | 633.6 | 1130.4 | 3.9501 | 23587442 | 33.33409723 | CS |
156 | -677.07 | -98.2970383275 | 688.8 | 1711.2 | 3.9501 | 8857997 | 39.31816133 | CS |
260 | -677.07 | -98.2970383275 | 688.8 | 1711.2 | 3.9501 | 8857997 | 39.31816133 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions